The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shpakov A.O.

Laboratoriia molekuliarnoĭ éndokrinologii Instituta évoliutsionnoĭ fiziologii i biokhimii im. I.M. Sechenova RAN, Sankt-Peterburg

Thienopyrimidines — the new class of low molecular weight regulators of the female reproductive system

Authors:

Shpakov A.O.

More about the authors

Journal: Problems of Endocrinology. 2015;61(2): 45‑49

Read: 714 times


To cite this article:

Shpakov AO. Thienopyrimidines — the new class of low molecular weight regulators of the female reproductive system. Problems of Endocrinology. 2015;61(2):45‑49. (In Russ.)
https://doi.org/10.14341/probl201561245-49

Recommended articles:
Vari­cose veins in chro­nic expe­riment. Piro­gov Russian Journal of Surgery. 2025;(7):16-23

References:

  1. Shpakov A.O. Strukturno-funkcional’naya organizaciya receptorov polipeptidnyh gormonov, soderzhashchih LRR-povtory, i ih vzaimodejstvie s geterotrimernymi G-belkami. Citologiya 2009;51:637–649.
  2. Puett D, Angelova K, da Costa MR, et al. The luteinizing hormone receptor: Insights into structure–function relationships and hormone-receptor-mediated changes in gene expression in ovarian cancer cells. Molecular and Cellular Endocrinology. 2010;329(1-2):47-55. doi: 10.1016/j.mce.2010.04.025.
  3. Puett D, Li Y, DeMars G, et al. A functional transmembrane complex: The luteinizing hormone receptor with bound ligand and G protein. Molecular and Cellular Endocrinology. 2007;260-262:126-136. doi: 10.1016/j.mce.2006.05.009.
  4. Heitman LH, Kleinau G, Brussee J, et al. Determination of different putative allosteric binding pockets at the lutropin receptor by using diverse drug-like low molecular weight ligands. Molecular and Cellular Endocrinology. 2012;351(2):326-336. doi: 10.1016/j.mce.2012.01.010.
  5. van Straten NCR, Schoonus-Gerritsma GG, van Someren RG, et al. The First Orally Active Low Molecular Weight Agonists for the LH Receptor: Thienopyr(im)idines with Therapeutic Potential for Ovulation Induction. Chem Bio Chem. 2002;3(10):1023-1026. doi: 10.1002/1439-7633(20021004)3:10<1023::aid-cbic1023>3.0.co;2-9.
  6. Shpakov AO, Shpakova EA. Nizkomolekulyarnye regulyatory receptorov polipeptidnyh gormonov, soderzhashchih LGR-povtory. Biomed himiya 2010;56:303–318.
  7. Heitman LH, Ijzerman AP. G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: A case for gnrh, LH, FSH, and GPR54 receptor ligands. Medicinal Research Reviews. 2008;28(6):975-1011. doi: 10.1002/med.20129.
  8. Lane JR, Ijzerman AP. Allosteric approaches to GPCR drug discovery. Drug Discovery Today: Technologies. 2013;10(2):e219-e221. doi: 10.1016/j.ddtec.2013.01.006.
  9. Heitman LH, Oosterom J, Bonger KM, et al. [3H]Org 43553, the First Low-Molecular-Weight Agonistic and Allosteric Radioligand for the Human Luteinizing Hormone Receptor. Molecular Pharmacology. 2007;73(2):518-524. doi: 10.1124/mol.107.039875.
  10. Moore S, Jaeschke H, Kleinau G, et al. Evaluation of Small-Molecule Modulators of the Luteinizing Hormone/Choriogonadotropin and Thyroid Stimulating Hormone Receptors:  Structure — Activity Relationships and Selective Binding Patterns. Journal of Medicinal Chemistry. 2006;49(13):3888-3896. doi: 10.1021/jm060247s.
  11. van Koppen CJ, Zaman GJR, Timmers CM, et al. A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor. Naunyn-Schmiedeberg’s Archives of Pharmacology. 2008;378(5):503-514. doi: 10.1007/s00210-008-0318-3.
  12. Shpakov AO, Dar’in DV, Derkach KV, Lobanov PS. Stimuliruyushchee vliyanie tienopirimidinovyh proizvodnyh na adenilatciklaznuyu signal’nuyu sistemu v semennikah krys Doklady Akademii nauk 2014;456:494–498
  13. Shpakov AO, Derkach KV, Dar’in DV, Lobanov PS. Aktivaciya adenilatciklazy tienopirimidinovymi proizvodnymi v semennikah i yaichnikah krys. Citologiya. 2014; 56: 346–352.
  14. van de Lagemaat R, Timmers CM, Kelder J, et al. Induction of ovulation by a potent, orally active, low molecular weight agonist (Org 43553) of the luteinizing hormone receptor. Human Reproduction. 2008;24(3):640-648. doi: 10.1093/humrep/den412.
  15. Derkach KV, Dar’in DV, Lobanov PS, SHpakov AO. Tienopirimidinovye proizvodnye povyshayut uroven’ testosterona pri ih intratestikulyarnom, vnutribryushinnom i peroral’nom vvedenii samcam krys. Doklady Akademii nauk. 2014;459(3):382-385.
  16. Gerrits M, Mannaerts B, Kramer H, et al. First Evidence of Ovulation Induced by Oral LH Agonists in Healthy Female Volunteers of Reproductive Age. The Journal of Clinical Endocrinology & Metabolism. 2013;98(4):1558-1566. doi: 10.1210/jc.2012-3404.
  17. van de Lagemaat R, Raafs BC, van Koppen C, et al. Prevention of the Onset of Ovarian Hyperstimulation Syndrome (OHSS) in the Rat After Ovulation Induction with a Low Molecular Weight Agonist of the LH Receptor Compared with hCG and rec-LH. Endocrinology. 2011;152(11):4350-4357. doi: 10.1210/en.2011-1077.
  18. de Boer P, van der Hoeven FA, Wolters EMTJ, Mattheij JAM. Embryo Loss, Blastomere Development and Chromosome Constitution after Human Chorionic Gonadotropin-Induced Ovulation in Mice and Rats with Regular Cycles. Gynecologic and Obstetric Investigation. 1991;32(4):200-205. doi: 10.1159/000293031.
  19. Goebel C. Stimulating luteinizing hormone. Drug Testing and Analysis. 2011;3(11-12):868-872. doi: 10.1002/dta.393.
  20. Latronico AC, Anasti J, Arnhold IJP, et al. Testicular and Ovarian Resistance to Luteinizing Hormone Caused by Inactivating Mutations of the Luteinizing Hormone–Receptor Gene. New England Journal of Medicine. 1996;334(8):507-512. doi: 10.1056/nejm199602223340805.
  21. Mizrachi D, Segaloff DL. Intracellularly Located Misfolded Glycoprotein Hormone Receptors Associate with Different Chaperone Proteins than Their Cognate Wild-Type Receptors. Molecular Endocrinology. 2004;18(7):1768-1777. doi: 10.1210/me.2003-0406.
  22. Newton CL, Whay AM, McArdle CA, et al. Rescue of expression and signaling of human luteinizing hormone G protein-coupled receptor mutants with an allosterically binding small-molecule agonist. Proceedings of the National Academy of Sciences. 2011;108(17):7172-7176. doi: 10.1073/pnas.1015723108.
  23. Janovick JA, Maya-Núñez G, Ulloa-Aguirre A, et al. Increased plasma membrane expression of human follicle-stimulating hormone receptor by a small molecule thienopyr(im)idine. Molecular and Cellular Endocrinology. 2009;298(1-2):84-88. doi: 10.1016/j.mce.2008.09.015.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.